Track the Natco Pharma Limited stock price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Natco Pharma Limited has recorded 76 public disclosures. Market capitalisation: €166.5bn. The latest transaction was filed on 11 March 2026 (Sale). Among the most active insiders: SATYA VANI NANNAPANENI. All data is openly available.
76
Insider Decl.
n/a
Thresholds
€572,962
28 ops.
Buy Volume
€7m
48 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Natco Pharma Limited Hold (neutral), based on 9 analysts. Average price target: ₹1,021.22.
10Σ signal
Buys €572,962€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,140 of 29,064 companies
80.3
score / 100
Value
73
Quality
87
FCF yld8.3%
Earn yld8.5%
EV/EBITDA10.0x
ROE17%
Gross mgn83%
Net mgn35%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
11,563 shares@ ₹1,460.484623.1% of flowEquity SharesSEBI:50ee1589d01fe3ab88b76bdb3d84a4ed4fa23b05
25 of 76 declarations
Acerca de Natco Pharma Limited
Natco Pharma Limited es una empresa farmacéutica india centrada en la investigación, desarrollo y fabricación de medicamentos genéricos y productos farmacéuticos. Cotiza en la Bolsa de Bombay.